Liposarcomas

This publication has 88 references indexed in Scilit:

• Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
  The Lancet Oncology, 2012
• PPARγ agonists enhance ET-743–induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma
  Journal of Clinical Investigation, 2012
• Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma
  Clinical Sarcoma Research, 2012
• Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma
  Laboratory Investigation, 2011
• Aberrant AKT activation drives well-differentiated liposarcoma
  Proceedings of the National Academy of Sciences, 2011
• Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma
  Current Opinion in Oncology, 2011
• An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors
  Laboratory Investigation, 2011
• Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
  Nature Genetics, 2010
• Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy
  BMC Cancer, 2009
• Patterns of care in a population‐based sample of soft tissue sarcoma patients in the United States
  Cancer, 2009